CLINICAL_TRIALS ClinicalTrials.gov record update

Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04498767
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:14.917906+00:00
Published At: 2024-08-26T00:00:00+00:00
Record Updated At: 2024-08-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Gynecologic Cancer", "Skin Cancer", "Head and Neck Cancer", "Sarcoma", "Renal Cancer", "Bladder Cancer", "Upper Urinary Tract Carcinoma", "Pancreatic Cancer", "Hepatobiliary Cancer", "Gastric Cancer", "Small Bowel Cancer", "Esophageal Cancer", "Melanoma", "Colon Cancer", "Oligometastasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-08-26"
protocolSection.identificationModule.nctId: "NCT04498767"
protocolSection.identificationModule.officialTitle: "Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.